Discontinuation of Angiotensin Converting Enzyme Inhibitors due to Dry Cough: Incidence and Clinical Determinants

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	563-563
Number of pages	1
Journal	Clinical Pharmacology & Therapeutics
Volume	105
Issue number	3
DOIs	https://doi.org/10.1002/cpt.1130
Publication status	Published - 2019

Research programs

@article{f52b03d8fe1043c1afa84709266007b3,

title = "Discontinuation of Angiotensin Converting Enzyme Inhibitors due to Dry Cough: Incidence and Clinical Determinants",

author = "Jasper Brugts",

year = "2019",

doi = "10.1002/cpt.1130",

language = "Undefined/Unknown",

volume = "105",

pages = "563--563",

journal = "Clinical Pharmacology & Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Discontinuation of Angiotensin Converting Enzyme Inhibitors due to Dry Cough: Incidence and Clinical Determinants

AU - Brugts, Jasper

PY - 2019

Y1 - 2019

U2 - 10.1002/cpt.1130

DO - 10.1002/cpt.1130

M3 - Article

C2 - 30005131

SN - 0009-9236

VL - 105

SP - 563

EP - 563

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

IS - 3

ER -